Rangeley Capital’s Generation Bio GBIO Stock Holding History

Rangeley Capital’s Portfolio GBIO Stock Details GBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-98,280	Closed	-$558K	–	146
2025 Q4	$558K	Buy	+98,280	New	+$555K	0.46%	45

Other funds holding GBIO

ACM

Accent Capital Management Centerville, Ohio $206M AUM 29.56% 1-Year Est. Return

Rangeley Capital's GBIO Position: Q1 2026 in Review

Rangeley Capital sold out of Generation Bio (GBIO) in Q1 2026, closing a stake of 98,280 shares — an estimated $558K sold.

Rangeley Capital first reported a position in GBIO in Q4 2025 and held it in 1 quarter. The position peaked at $558K in Q4 2025. 2 funds tracked by Wall St. Rank hold GBIO as of Q1 2026.

Rangeley Capital reported no remaining Generation Bio position as of Q1 2026 after selling out during the quarter.
Rangeley Capital sold 98,280 Generation Bio shares in Q1 2026, an estimated $558K.
Rangeley Capital first reported a position in Generation Bio in Q4 2025 and held it in 1 quarter.
Rangeley Capital's Generation Bio position peaked at $558K in Q4 2025.
2 funds tracked by Wall St. Rank held Generation Bio as of Q1 2026.

Based on Rangeley Capital's 13F filing for Q1 2026, filed 15 May 2026.